Literature DB >> 16140679

Worse quality of life for children with newly diagnosed attention-deficit/hyperactivity disorder, compared with asthmatic and healthy children.

Rodrigo Escobar1, Cesar A Soutullo, Amaia Hervas, Xavier Gastaminza, Pepa Polavieja, Inmaculada Gilaberte.   

Abstract

OBJECTIVE: To evaluate the quality of life (QOL) of untreated children with newly diagnosed attention-deficit/hyperactivity disorder (ADHD), compared with asthmatic and healthy children.
METHODS: This prospective, case-control study included a group of 120 children, 6 to 12 years of age, with newly diagnosed ADHD according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Subjects were matched according to age, gender, and health care area with 2 control groups, ie, 93 asthmatic children and 120 healthy children. Sociodemographic characteristics and Child Health Questionnaire scores were collected.
RESULTS: The QOL of children with ADHD was rated worse than that of asthmatic or healthy children for most Child Health Questionnaire domains. The greatest differences were found in behavior, social limitations attributable to physical problems, emotional impact on parents, and family activities. Almost every psychosocial domain was more affected in comparison with asthmatic children and both psychosocial and physical domains in comparison with healthy children.
CONCLUSIONS: ADHD interferes with the daily lives of children, parents, and families even more than asthma, primarily in areas related to psychosocial functioning, although evidence of impaired physical functioning also emerged. Delays in recognition, assessment, and management of ADHD may affect negatively the QOL of those children.

Entities:  

Mesh:

Year:  2005        PMID: 16140679     DOI: 10.1542/peds.2005-0386

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  45 in total

1.  Long-term course of ADHD symptoms from childhood to early adulthood in a community sample.

Authors:  Manfred Döpfner; Christopher Hautmann; Anja Görtz-Dorten; Fionna Klasen; Ulrike Ravens-Sieberer
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-11-14       Impact factor: 4.785

2.  Extended-release medications for children and adolescents with attention-deficit hyperactivity disorder.

Authors:  M Feldman; S Bélanger
Journal:  Paediatr Child Health       Date:  2009-11       Impact factor: 2.253

3.  Factors related to health-related quality of life (HRQoL) among children with ADHD in Europe at entry into treatment.

Authors:  Anne W Riley; Georg Spiel; David Coghill; Manfred Döpfner; Bruno Falissard; Maria J Lorenzo; Ulrich Preuss; Stephen J Ralston
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-12       Impact factor: 4.785

4.  Unmet needs associated with attention-deficit/hyperactivity disorder in eight European countries as reported by caregivers and adolescents: results from qualitative research.

Authors:  Vanja Sikirica; Emuella Flood; C Noelle Dietrich; Javier Quintero; Val Harpin; Paul Hodgkins; Klaus Skrodzki; Kathleen Beusterien; M Haim Erder
Journal:  Patient       Date:  2015-06       Impact factor: 3.883

5.  Study design, baseline patient characteristics and intervention in a cross-cultural framework: results from the ADORE study.

Authors:  Ulrich Preuss; Stephen J Ralston; Gisli Baldursson; Bruno Falissard; Maria J Lorenzo; Rob Rodrigues Pereira; Laurens Vlasveld; David Coghill
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-12       Impact factor: 4.785

6.  Health care needs of children with Tourette syndrome.

Authors:  Rebecca H Bitsko; Melissa Danielson; Michael King; Susanna N Visser; Lawrence Scahill; Ruth Perou
Journal:  J Child Neurol       Date:  2012-11-08       Impact factor: 1.987

7.  Self-esteem in adolescent patients with attention-deficit/hyperactivity disorder during open-label atomoxetine treatment: psychometric evaluation of the Rosenberg Self-Esteem Scale and clinical findings.

Authors:  Ralf W Dittmann; Peter M Wehmeier; Alexander Schacht; Martin Lehmann; Gerd Lehmkuhl
Journal:  Atten Defic Hyperact Disord       Date:  2009-09-23

8.  Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD).

Authors:  L Hakkaart-van Roijen; B W C Zwirs; C Bouwmans; S S Tan; T W J Schulpen; L Vlasveld; J K Buitelaar
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-05-04       Impact factor: 4.785

9.  Effects of clonidine and methylphenidate on family quality of life in attention-deficit/hyperactivity disorder.

Authors:  Michael Cannon; William H Pelham; F Randy Sallee; Donna R Palumbo; Oscar Bukstein; W Burl Daviss
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-10       Impact factor: 2.576

10.  Atomoxetine treatment and ADHD-related difficulties as assessed by adolescent patients, their parents and physicians.

Authors:  Ralf W Dittmann; Peter M Wehmeier; Alexander Schacht; Anette Minarzyk; Martin Lehmann; Kathrin Sevecke; Gerd Lehmkuhl
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2009-08-24       Impact factor: 3.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.